| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |